61703-305Level 3
Cytarabine (CYTARABINE)
**Product type:** Human Prescription Drug
**Active ingredient:** CYTARABINE
**Strength:** 20 mg/mL
**Dosage form:** Injection, Solution
**Route:** Intrathecal; Intravenous; Subcutaneous
**Labeler:** Hospira, Inc.
**Marketing category:** ANDA (ANDA071868)
**Pharmacologic class:** Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
GET
/api/v1/systems/ndc_fda/nodes/61703-305Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.